| Drug Name |
Chloramphenicol sodium succinate |
| Drug ID |
BADD_D00431 |
| Description |
Chloramphenicol succinate is an ester prodrug of [chloramphenicol].[A192987] Chloramphenicol is a bacteriostatic antibiotic.[A204065] Use of chloramphenicol succinate and chloramphenicol has decreased due to the risk of potentially fatal blood dyscrasias.[L14174]
Chloramphenicol succinate was granted FDA approval on 20 February 1959.[L12711] |
| Indications and Usage |
Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
D06AX02; D10AF03; G01AA05; J01BA01; S01AA01; S02AA01; S03AA08 |
| DrugBank ID |
DB07565
|
| KEGG ID |
D02185
|
| MeSH ID |
C026016
|
| PubChem ID |
656833
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
63323-011 |
| Synonyms |
chloramphenicol succinate | levomycetin succinate | chloramphenicol hemisuccinate | chloramphenicol monosuccinate | chloramphenicol succinate sodium | chloramphenicol sodium succinate |
